Jun Horiguchi

368 papers receiving 8.7k citations

Jun Horiguchi's Hit Papers

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study 2020 · 676 citations
6760+2+4Years since publication200400600

Peers

Jun Horiguchi
Comparison fields: 5 of 133
  • Biological Psychiatry 213
  • Cancer Research 1.3k
  • Radiology, Nuclear Medicine and Imaging 1.5k
  • Psychiatry and Mental health 1k
  • Oncology 1.1k
Replace Robert J. Dempsey with:
Robert J. Dempsey United States
Keiji Sano Japan
Marinus A. Blankenstein Netherlands
Giovanni Lombardi Italy
Flemming W. Bach Denmark
Yun Xu China
Alberto Rícci Italy
José Castillo Spain
Kiyoshi Maeda Japan
Lutz Hein Germany
Jun Horiguchi relative to Robert J. Dempsey United States Robert J. Dempsey's profile →
Citations per field
00.5×2×4×5.6×
Robert J. Dempsey · 1×
Citations per year

Countries citing papers authored by Jun Horiguchi

Since Specialization
Citations

This map shows the geographic impact of Jun Horiguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Horiguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Horiguchi more than expected).

Fields of papers citing papers by Jun Horiguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Horiguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Horiguchi. The network helps show where Jun Horiguchi may publish in the future.

Co-authors

The 25 scholars most cited alongside Jun Horiguchi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jun Horiguchi Line = papers co-authored together Jun Horiguchi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 391 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
Hit paper breakdown →
2020676
2 2008264
3 2018232
4 2005227
5 2008225
6 2012190
7 2009163
8 2011163
9 2012152
10 2016135
11 2008131
12 200696
13 200394
14 201188
15 200579
16 200374
17 200774
18 201273
19 201072
20 200071

About Jun Horiguchi

Jun Horiguchi is a scholar working on Cancer Research, Psychiatry and Mental health, Oncology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine, having authored 391 papers that have together received 9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (75 papers), Schizophrenia research and treatment (51 papers), Cardiac Imaging and Diagnostics (35 papers), Breast Lesions and Carcinomas (24 papers), HER2/EGFR in Cancer Research (18 papers), Estrogen and related hormone effects (14 papers), Restless Legs Syndrome Research (12 papers) and Dementia and Cognitive Impairment Research (9 papers). The work is most often cited by research in Biological Psychiatry (213 citations), Cancer Research (1.3k citations), Radiology, Nuclear Medicine and Imaging (1.5k citations), Psychiatry and Mental health (1k citations) and Oncology (1.1k citations). Jun Horiguchi has collaborated with scholars based in Japan, United States and Indonesia. Frequent co-authors include Tsuyoshi Miyaoka, Takuji Inagaki, Katsuhide Ito, Tetsunari Oyama, Hideya Yamamoto, Yasushi Inami, Toshiro Kitagawa, Soichi Mizuno, Hideaki YASUDA and Sasagu Kurozumi. Their work appears in journals such as Breast Cancer, Psychiatry and Clinical Neurosciences, Oncology Reports, Progress in Neuro-Psychopharmacology and Biological Psychiatry and American Journal of Roentgenology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact